Latest News
Latest News
  • Home
  • Video Shows
    VantageFirstpost AmericaFirstpost AfricaFirst Sports
  • World
    US News
  • Explainers
  • News
    IndiaOpinionCricketTechEntertainmentSportsHealthPhotostories
  • India vs Australia
TrendingDonald TrumpNarendra ModiElon MuskUnited StatesJoe Biden
Latest News

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit

Dgci

Recent Highlights

Government panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose

Government panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose

.
Sputnik Light, J&J take another step towards joining India's COVID vaccine arsenal

Sputnik Light, J&J take another step towards joining India's COVID vaccine arsenal

.
Kolkata hospital awaits DGCI nod to begin Phase 2 trial of Russia's Sputnik V COVID-19 vaccine

Kolkata hospital awaits DGCI nod to begin Phase 2 trial of Russia's Sputnik V COVID-19 vaccine

.
Covaxin, Bharat Biotech's COVID-19 vaccine candidate, gets DCGI nod for Phase 3 trials

Covaxin, Bharat Biotech's COVID-19 vaccine candidate, gets DCGI nod for Phase 3 trials

.

All Stories for Dgci

All (8)
  • Oxford COVID-19 vaccine: Panel recommends that DCGI grant Serum Institute permission for human trials

    Oxford COVID-19 vaccine: Panel recommends that DCGI grant Serum Institute permission for human trials

    • .

    The DCGI had earlier asked SII to clearly define Phase 2 and Phase 3 of trials and resubmit their application for evaluation.

  • COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients

    COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients

    Myupchar • .

    Favipiravir is an antiviral drug which was developed by a Japanese pharma company, Fujifilm Toyama Chemical, to treat influenza.

  • GJEPC denies four-fold surge in imports of cut and polished diamonds, says there has actually been a 4.3% decline

    GJEPC denies four-fold surge in imports of cut and polished diamonds, says there has actually been a 4.3% decline

    Fp Staff • .

    Actual imports of cut and polished diamonds for this period stand at $1,527.43 million, and represent a decline of 14.44 percent as compared to $1,785.17 million for April-November 2016.

  • Biocon reports Q3 net profit of Rs 105 cr, up 14%

    Biocon reports Q3 net profit of Rs 105 cr, up 14%

    Fp Archives • .

    The key highlight was the DCGI approval for our biosimilar Trastuzumab, which paved the way for its commercial launch in India as CANMAb.<br /><br />

  • Home
  • dgci

About Firstpost

Most Searched Categories

  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025

NETWORK18 SITES

  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
youtube
youtube

is on YouTube

Subscribe Now

Copyright @ 2025. Firstpost - All Rights Reserved.

Contact Us Privacy Policy Cookie Policy Terms Of Use
HomeVideosShortsLive TV